Muscle Stimulator Market Expected to Reach $0.18 Billion by 2030

According to a new report published by Allied Market Research, titled, “Muscle Stimulator Market by Product type, Modality, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," The global muscle stimulator market size was valued at $1,22,460.00 thousand in 2020, and is projected to reach $1,83,887.64 thousand by 2030, registering a CAGR of 4.08% from 2021 to 2030. Electrical muscle stimulation (EMS), also known as neuromuscular electrical stimulation (NMES) or electromyostimulation, is a protocol that activates muscle contraction using electrical impulses that directly stimulate motor neurons. Muscle stimulants use sinusoidal output. The sensory nerves are reactivated in a way that interferes with the perception of pain through gate control or opiate system mechanisms. Motor sensory stimulation stimulates muscle contraction. Strength and frequency of muscle contraction can be used to relieve muscular spasm, muscle exercise, and reduce edema.

Physical instability, lack of stamina activities, and unhealthy eating habits are common causes of muscle disorders, which drive the growth of the muscle stimulator market. In addition, technological advancements in products such as PowerDot have projected to increase the demand for muscle stimulator market. Moreover, rise in the demand is evident due to the wireless and portable muscle stimulator and their compatibility with smartphones boost the growth of market. However, lack of usage guidelines and safety concerns, regulatory uncertainties in the U.S., and availability of alternative therapies pose to restrain the growth of the muscle stimulator market. Conversely, rise in the technology integration is expected to offer lucrative opportunities during the forecast period.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has limited the industry growth significantly, as the demand for muscle stimulator device decreased, owing to decline in diagnostics and surgical procedures in the first half of 2020. According to the study published in the British Journal of Surgery, around 28.4 million elective procedures were cancelled or postponed in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19. Thus, the outbreak of COVID-19 has negatively impacted the growth of the muscle stimulator market.

The muscle stimulator market is segmented on the basis of product type, modality, application, end user, and region. By product type, the market is divided into neuromuscular electrical stimulation, functional electrical stimulation, interferential, burst mode alternating current, micro current electrical neuromuscular stimulator, and others. On the basis of modality, the market is categorized into portable & handheld and table top. Depending on application, it is segregated into pain management, muscle rehabilitation, muscle atrophy, muscle toning &strengthening, muscle spasticity & spasms, others. As per end user, it is classified into physical therapy & rehabilitation clinics, hospitals, ambulatory surgery centers, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By product type, the neuromuscular electrical stimulation generated the highest revenue in 2020, and is expected to show fastest growth rate in the forecast period. This is attributed to rise in prevalence of arthritis and increasing sports injuries. Moreover, rise in geriatric population and surge in demand for use of muscle stimulators have influenced companies to focus on the development of electrical muscle stimulators also contributes to growth of the muscle stimulator market.

On the basis of modality, the portable & handheld segment had the highest revenue in 2020. Major factors that influenced the market growth include key players launching innovative portable muscle stimulator devices to sustain market competition.

Depending on application, the muscle rehabilitation segment garnered the highest revenue in 2020. Moreover, pain management segment is expected to show the fastest growth rate in the forecast period. Major factors that influenced the market growth include increase in cases of chronic & acute pain and the need for effective pain management therapies among cancer patients.

By end user, the physical therapy & rehabilitation clinics segment dominated the global market in 2020, and is also expected to show the fastest growth rate during the forecast period. This was attributed to the fact that include surge in preference of physiotherapists toward stimulators as compared to manual techniques.

In 2020, North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, well-developed healthcare infrastructure, and favorable reimbursement policies in healthcare system. However, Asia-Pacific is expected to grow at the fastest CAGR, owing to increase in number of incidences of musculoskeletal disorders and rise in awareness related to electrical muscle stimulation therapy.

Key Findings Of The Study

• On the basis of product type, the neuromuscular electrical stimulation segment held largest muscle stimulator market share in 2020, and is expected to remain dominant throughout the forecast period.
• By modality, the portable and handheld segment held largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• Depending on application, the muscle rehabilitation segment held largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• As per end user, physical therapy and rehabilitation clinics segment held largest muscle stimulator market share in 2020, and is expected to remain dominant throughout the forecast period.
• Region wise, North-America is expected to experience growth at the highest rate, registering a CAGR of 3.57% during the forecast period.